BUFFALO, N.Y. — Buffalo Police are investigating an incident on Sherman Street which resulted in a police officer being shot. In a press conference, Buffalo Police Commissioner Erika Shields said that ...

A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi as a first-line treatment for diffuse large B-cell lymphoma (DLBCL). The ...

Varying degrees of cognitive impairment have been documented during the course of cancer treatment [...]. The data that support the findings of this study and codes for statistical analyses are ...

1 Department of Cardiology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei 442008, China 2 Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical ...

Sunlight has proven to be an excellent formgiver, with which architecture can create dynamic environments. The lighting design pioneer William M.C. Lam (1924-2012) emphasized in his book “Sunlighting ...

Coronary artery disease (CAD) patterns play an essential role in the decision‐making process about revascularization. The pullback pressure gradient (PPG) quantifies CAD patterns as either focal or ...

Between 1970 and 1995, the incidence of new NHL cases increased. Between 2007 and 2016, new cases declined by approximately 0.9% per year, and mortality from NHL decreased by 2.2% per year. 3 ...

Xanthoma pathogenesis is speculated to be associated with oxidized low-density lipoprotein (ox-LDL) deposition, although this remains unclear. Most patients with diffuse plane xanthomas present ...

Diffuse large B-cell lymphoma (DLBCL) is typically treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, only 60% of patients are cured with R-CHOP.

An 11-year-old boy with autism and focal idiopathic epilepsy presented to the emergency department at an outside hospital after sudden onset of recurrent vomiting. He was nonverbal at baseline and ...

3 University of Michigan School of Medicine, Scleroderma Program, Ann Arbor, United States of America 4 Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, United States ...